Kabra Drugs Ltd.
BSE: 524322 | Sector: Health care |
NSE: N.A. | ISIN Code: INE323K01017 |
BSE 00:00 | 01 Feb | 4.50 |
0.20 (4.65%) |
OPEN
4.51 |
HIGH
4.51 |
LOW
4.11 |
NSE 05:30 | 01 Jan | Kabra Drugs Ltd |
OPEN | 4.51 |
PREVIOUS CLOSE | 4.30 |
VOLUME | 263 |
52-Week high | 5.70 |
52-Week low | 2.95 |
P/E | |
Mkt Cap.(Rs cr) | 2 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Kabra Drugs Ltd. (KABRADRUGS) - Yearly Result
Particulars (![]() |
Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 |
Net Sales/Income From Operations | 0.00 | 0.00 | 0.02 | 0.01 | 2.01 |
Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Total Income | 0.00 | 0.00 | 0.02 | 0.01 | 2.02 |
Total Expenditure | 0.18 | 0.15 | 0.05 | 0.14 | 3.99 |
Operating Profit | -0.18 | -0.15 | -0.03 | -0.13 | -1.97 |
Interest | 0.00 | 0.00 | 0.03 | 0.01 | 0.25 |
Gross Profit | -0.18 | -0.15 | -0.06 | -0.13 | -2.22 |
Depreciation | 0.01 | 0.03 | 0.00 | 0.03 | 0.14 |
PBT | -0.19 | -0.18 | -0.06 | -0.16 | -2.36 |
Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit/(Loss) | -0.19 | -0.18 | -0.06 | -0.16 | -2.36 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -0.95 |
Profit After Exceptional Items | -0.19 | -0.18 | -0.06 | -0.16 | -1.41 |
Equity Share Capital | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 |
Reserves Excluding Revaluation Reserves | -4.78 | -4.60 | -4.42 | -4.36 | -4.19 |
EPS | |||||
Basic EPS | -0.42 | -0.41 | -0.14 | -0.38 | -5.37 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Kabra Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices